Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
01. August 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9509
Articles 1 - 20 / 190176
Effects of tadalafil on endothelial, angiogenic, metabolic, and microRNA biomarker profiles in sexually active men with BPH and erectile dysfunction: a randomized controlled trial.
Naunyn Schmiedebergs Arch Pharmacol
Abomandour A, El-Shoura EAM, Fathi BA, Elewa HA, Abd-Eldayem AM, Zalat ZA.
PMID: 42538422 [PubMed - as supplied by publisher]
Performance of Urine Tumor DNA Detection in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection.
Eur Urol Focus
Ogunkeye J, Shkolyar E, Mach KE, Prendiville S, Prado K, Shah JB, Skinner EC, Fischer DS, Phillips KG, Bicocca VT, Levin TG, Liao JC.
PMID: 42538173 [PubMed - as supplied by publisher]
Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance.
Cancer Treat Res Commun
Bogale DE.
PMID: 42537446 [PubMed - as supplied by publisher]
Venous thromboembolism in urothelial bladder cancer - scope of the problem and patients' perspectives: VTE-UBC.
Wiad Lek
Abdullah OR, Short K, Alomari LHF, Ignatowicz A, Young A.
PMID: 42536929 [PubMed - indexed for MEDLINE]
Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.
Oncology (Williston Park)
Rodríguez-Olivares JL, Mauricio Mora Pineda Md, Beas-Lozano E, Alec Seidman-Sorsby Md, Remolina-Bonilla YA, Armando Gamboa-Domínguez Md, Jeffrey Weitzel Md Facmg, Pedro Barata Md MSc, Yanin Chavarri-Guerra Md MSc Fasco, Bourlon MT.
PMID: 42536596 [PubMed - indexed for MEDLINE]
An immunohistochemical diagnostic panel for Xp11.2 translocation renal cell carcinoma: A diagnostic accuracy study.
Medicine (Baltimore)
Wei M, Pan B, Yang W, Xu W, Dong J.
PMID: 42536557 [PubMed - indexed for MEDLINE]
Changes in lower urinary tract symptoms and uroflowmetric parameters after CPAP therapy in patients with obstructive sleep apnea syndrome and benign prostatic hyperplasia: A retrospective study.
Medicine (Baltimore)
, Erbay G, Çiçek S, , Kiliçarslan M.
PMID: 42536520 [PubMed - indexed for MEDLINE]
Risk of bladder cancer among male participants reporting nocturia in the Cancer Prevention Study-II.
Cancer Epidemiol Biomarkers Prev
Zhong C, Masters M, Donzella SM, Bliwise DL, Parsons H, Rees-Punia E.
PMID: 42536351 [PubMed - as supplied by publisher]
Transient and persistent urinary incontinence after thulium fiber laser enucleation of the prostate (ThuFLEP): long-term trends and predictive factors in a real-world cohort.
World J Urol
Caillault V, Audige V, Lenfant L, Parra J, Vaessen C, Beaugerie A, Mozer P, Dubourg Q, Felber M, Seisen T, Chartier-Kastler E, Roupret M, Pinar U.
PMID: 42536200 [PubMed - indexed for MEDLINE]
Decision regret and patient satisfaction after TURP and Rezūm™ for benign prostatic obstruction: a retrospective comparative cohort study.
World J Urol
Lagos-Beitz HE, Martínez-Delgado GH, Sanchez-Torres S, Neri-Moguel G, Valencia-Álvarez FR, Trujillo-Martínez G, Escalante-Armenta R, Alcacio-Mendoza JA, Castillejos-Molina RA, Mendez-Probst CE.
PMID: 42536184 [PubMed - indexed for MEDLINE]
Surgical management of acquired bladder diverticula in adult men: a scoping review.
World J Urol
Bakbak H, Singh G, Zavos TM, Rathinam A, Panqueva Baena T, Abdelaziz A, Katz JE, Marcovich R, Wein AJ, Shah HN.
PMID: 42536118 [PubMed - indexed for MEDLINE]
Circadian Gene Networks and Transcriptome Oscillations in Prostate Cancer: Insights From RNA Sequencing and Implications for Chronotherapy.
Cureus
Bivolarski I, Dimitrov M, Dechev H.
PMID: 42535191 [PubMed]
Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management.
Front Oncol
Bakshi G, Lyon A, Joshi A, Agarwala V, Raghunath SK, Addla SK, Taneja R, Mandani A, Kashyapi B, Bhargava S, Sharma R, Agrawal V, Nagar R, Srivathsan R, Patel K, Patel R, Shah H, Lai A, Mukherjee A, Pandey S, Rajput A.
PMID: 42534891 [PubMed]
AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.
Front Oncol
Chu T, Zhang Y, Du J, Mierxiati A.
PMID: 42534734 [PubMed]
Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).
Mol Clin Oncol
N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S.
PMID: 42534213 [PubMed]
[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.
Int J Urol
Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N.
PMID: 42533777 [PubMed - indexed for MEDLINE]
Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.
Int J Urol
Matsushita Y, Kita Y, Mukai S, Joraku A, Kobayashi I, Daizumoto K, Sano T, Nakanishi S, Watanabe J, Hatakeyama S, Goriki A, Hazama T, Nishiyama N, Mori K, Kitamura H, Kimura T, Matsui Y, Miyake M, Kobayashi T, Inamoto T, Japanese Urological Oncology Group.
PMID: 42533764 [PubMed - indexed for MEDLINE]
Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer.
Geriatr Gerontol Int
Kurokawa K, Yamamoto S, Higa K, Bamba H, Kanaoka S, Nakamura K.
PMID: 42533722 [PubMed - indexed for MEDLINE]
Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of (1)â¸F-NaF PET/CT.
Mol Imaging Biol
Zirakchian Zadeh M.
PMID: 42533239 [PubMed - as supplied by publisher]
Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
J Nucl Med
Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J.
PMID: 42532646 [PubMed - as supplied by publisher]
Articles 1 - 20 / 190176
Page 1 of 9509
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy